Samsara Therapeutics
Focus: Samsara Therapeutics is a UK-based small molecule biotech company founded in 2019, publicly listed and focused on drug development across undisclosed therapeutic areas.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
303+370 this month
Hot — 394 jobs added in 30d
Net +370 (394 new, 24 removed). Aggressive expansion phase.
Should You Work at Samsara Therapeutics?
AI assessmentExercise caution—public status is a plus, but lack of active hiring, visible pipeline, and financial transparency suggest this company is either in stealth mode or facing headwinds that warrant deeper due diligence before committing.
Why Work Here
- Public company status provides equity liquidity and stability relative to private biotech
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Samsara Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.